scholarly journals Blimp-1 controls plasma cell function through the regulation of immunoglobulin secretion and the unfolded protein response

2016 ◽  
Vol 17 (3) ◽  
pp. 323-330 ◽  
Author(s):  
Julie Tellier ◽  
Wei Shi ◽  
Martina Minnich ◽  
Yang Liao ◽  
Simon Crawford ◽  
...  
Keyword(s):  
Unfolded Protein Response ◽  
Plasma Cell ◽  
Cell Function ◽  
Immunoglobulin Secretion ◽  
Unfolded Protein ◽  
The Unfolded Protein Response ◽  
Protein Response

scholarly journals Enforced dimerization between XBP1s and ATF6f enhances the protective effects of the unfolded protein response (UPR) in models of neurodegeneration

2020 ◽  
Author(s):  
René L. Vidal ◽  
Denisse Sepulveda ◽  
Paulina Troncoso-Escudero ◽  
Paula Garcia-Huerta ◽  
Constanza Gonzalez ◽  
...  
Keyword(s):  
Gene Expression ◽  
Unfolded Protein Response ◽  
Target Genes ◽  
Cell Function ◽  
Alpha Synuclein ◽  
Protective Effects ◽  
Unfolded Protein ◽  
The Unfolded Protein Response ◽  
Protein Response

AbstractAlteration to endoplasmic reticulum (ER) proteostasis is observed on a variety of neurodegenerative diseases associated with abnormal protein aggregation. Activation of the unfolded protein response (UPR) enables an adaptive reaction to recover ER proteostasis and cell function. The UPR is initiated by specialized stress sensors that engage gene expression programs through the concerted action of the transcription factors ATF4, ATF6f, and XBP1s. Although UPR signaling is generally studied as unique linear signaling branches, correlative evidence suggests that ATF6f and XBP1s may physically interact to regulate a subset of UPR-target genes. Here, we designed an ATF6f-XBP1s fusion protein termed UPRplus that behaves as a heterodimer in terms of its selective transcriptional activity. Cell-based studies demonstrated that UPRplus has stronger an effect in reducing the abnormal aggregation of mutant huntingtin and alpha-synuclein when compared to XBP1s or ATF6 alone. We developed a gene transfer approach to deliver UPRplus into the brain using adeno-associated viruses (AAVs) and demonstrated potent neuroprotection in vivo in preclinical models of Parkinson’s and Huntington’s disease. These results support the concept where directing UPR-mediated gene expression toward specific adaptive programs may serve as a possible strategy to optimize the beneficial effects of the pathway in different disease conditions.

scholarly journals The Unfolded Protein Response: A Pathway That Links Insulin Demand with β-Cell Failure and Diabetes

2008 ◽  
Vol 29 (3) ◽  
pp. 317-333 ◽  
Author(s):  
Donalyn Scheuner ◽  
Randal J. Kaufman
Keyword(s):  
Cell Death ◽  
Protein Folding ◽  
Unfolded Protein Response ◽  
Secretory Pathway ◽  
Cell Function ◽  
Mrna Translation ◽  
Β Cell ◽  
Unfolded Protein ◽  
The Unfolded Protein Response ◽  
Protein Response

Abstract The endoplasmic reticulum (ER) is the entry site into the secretory pathway for newly synthesized proteins destined for the cell surface or released into the extracellular milieu. The study of protein folding and trafficking within the ER is an extremely active area of research that has provided novel insights into many disease processes. Cells have evolved mechanisms to modulate the capacity and quality of the ER protein-folding machinery to prevent the accumulation of unfolded or misfolded proteins. These signaling pathways are collectively termed the unfolded protein response (UPR). The UPR sensors signal a transcriptional response to expand the ER folding capacity, increase degredation of malfolded proteins, and limit the rate of mRNA translation to reduce the client protein load. Recent genetic and biochemical evidence in both humans and mice supports a requirement for the UPR to preserve ER homeostasis and prevent the β-cell failure that may be fundamental in the etiology of diabetes. Chronic or overwhelming ER stress stimuli associated with metabolic syndrome can disrupt protein folding in the ER, reduce insulin secretion, invoke oxidative stress, and activate cell death pathways. Therapeutic interventions to prevent polypeptide-misfolding, oxidative damage, and/or UPR-induced cell death have the potential to improve β-cell function and/or survival in the treatment of diabetes.

Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1

10.1038/ni907 ◽  
2003 ◽  
Vol 4 (4) ◽  
pp. 321-329 ◽  
Author(s):  
Neal N. Iwakoshi ◽  
Ann-Hwee Lee ◽  
Prasanth Vallabhajosyula ◽  
Kevin L. Otipoby ◽  
Klaus Rajewsky ◽  
...  
Keyword(s):  
Transcription Factor ◽  
Cell Differentiation ◽  
Unfolded Protein Response ◽  
Plasma Cell ◽  
Plasma Cell Differentiation ◽  
Unfolded Protein ◽  
The Unfolded Protein Response ◽  
Protein Response

scholarly journals The Pancreatic ß-cell Response to Secretory Demands and Adaption to Stress

Endocrinology ◽  
2021 ◽  
Vol 162 (11) ◽  
Author(s):  
Michael A Kalwat ◽  
Donalyn Scheuner ◽  
Karina Rodrigues-dos-Santos ◽  
Decio L Eizirik ◽  
Melanie H Cobb
Keyword(s):  
Unfolded Protein Response ◽  
Cell Function ◽  
Protein Translation ◽  
Insulin Production ◽  
Β Cells ◽  
Β Cell ◽  
Compensatory Mechanisms ◽  
Unfolded Protein ◽  
The Unfolded Protein Response ◽  
Protein Response

Abstract Pancreatic β cells dedicate much of their protein translation capacity to producing insulin to maintain glucose homeostasis. In response to increased secretory demand, β cells can compensate by increasing insulin production capability even in the face of protracted peripheral insulin resistance. The ability to amplify insulin secretion in response to hyperglycemia is a critical facet of β-cell function, and the exact mechanisms by which this occurs have been studied for decades. To adapt to the constant and fast-changing demands for insulin production, β cells use the unfolded protein response of the endoplasmic reticulum. Failure of these compensatory mechanisms contributes to both type 1 and 2 diabetes. Additionally, studies in which β cells are “rested” by reducing endogenous insulin demand have shown promise as a therapeutic strategy that could be applied more broadly. Here, we review recent findings in β cells pertaining to the metabolic amplifying pathway, the unfolded protein response, and potential advances in therapeutics based on β-cell rest.

Sign in / Sign up

Export Citation Format

Share Document